Affiliation:
1. Hazleton Wisconsin, P.O. Box 7545, Madison, Wisconsin
53707-7545
Abstract
Regulatory guidelines for prelinical safety assessment studies of new drugs, chemicals, and food additives exist in many large industrial countries. Current guidelines include recommendations or requirements for clinical pathology testing. Many of the testing requirements are similar for every country, but others are not. The similarities and differences among several of the guidelines are discussed, and specific instances of ambiguous or inappropriate testing requirements are cited.
Subject
Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interpretation of Hematologic Data in Nonclinical Studies;Schalm's Veterinary Hematology;2022-03-04
2. Clinical Pathology in Nonclinical Toxicity Testing;Haschek and Rousseaux's Handbook of Toxicologic Pathology;2022
3. Clinical Pathology Assays in Immunopathology;Immunopathology in Toxicology and Drug Development;2017
4. Current Practices in Preclinical Drug Development;Toxicologic Pathology;2012-09-18
5. Blood and bone marrow toxicity;Veterinary Toxicology;2012